Univest
Univest
  • Markets

3 Rating, Wealth and Insurance Franchise Stocks With a Strong Future Roadmap: CARE Ratings, Edelweiss Financial Services and Life Insurance Corporation of India

  • October 12, 2026
  • Posted by: Kunal Singla
  • Category: Best Stocks
No Comments
3 Rating, Wealth and Insurance Franchise Stocks With a Strong Future Roadmap: CARE Ratings, Edelweiss Financial Services and Life Insurance Corporation of India

CARE Ratings Rs 1,544.20, P/E 25.70. Edelweiss Rs 127.89, P/E 16.98. LIC Rs 394.25, P/E 7.99. Closing prices of 9 Oct 2026.

Quick Answer

Rating, wealth and insurance franchise stocks with the clearest long-term roadmaps today include CARE Ratings in credit ratings and analytics, Edelweiss in asset management, wealth management and insurance and LIC in life insurance and annuities through a vast agent network. FY26 revenue growth was 16.5% at CARE Ratings, 14.1% at Edelweiss and 10.2% at LIC. P/E stands at 25.70 for CARE Ratings (industry 33.32), 16.98 for Edelweiss (industry 17.72) and 7.99 for LIC (industry 10.30). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.

Rating, wealth and insurance franchise stocks give investors exposure to ratings, savings and insurance products that companies and households rely on. Fee income, premium growth and market activity decide how much of that demand turns into profit.

This list covers three rating, wealth and insurance franchise stocks: CARE Ratings for credit ratings and analytics, Edelweiss Financial Services for asset management, wealth management and insurance and Life Insurance Corporation of India for life insurance and annuities through a vast agent network. Every figure comes from the latest reported financials and the 9 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Are Rating, Wealth and Insurance Franchise Stocks?
  • Rating, Wealth and Insurance Franchise Stocks at a Glance
  • Why Do Rating, Wealth and Insurance Franchise Stocks Have a Strong Roadmap in India?
  • CARE Ratings: Rating Fees Anchor the Roadmap
  • Edelweiss Financial Services: Asset Management and Wealth Drive the Pipeline
  • Life Insurance Corporation of India: A Vast Policyholder Base Anchors the Roadmap
  • Best Rating, Wealth and Insurance Franchise Stocks in India: CARE Ratings vs Edelweiss vs LIC on Key Financials
  • How to Evaluate Rating, Wealth and Insurance Franchise Stocks to Buy Before You Invest
  • Risks to Consider Before Investing in Rating, Wealth and Insurance Franchise Stocks
  • Final Take: Which Stock Has the Strongest Roadmap?
  • FAQs on Rating, Wealth and Insurance Franchise Stocks
    • Which are the best rating, wealth and insurance franchise stocks in India with a strong roadmap?
    • Is CARE Ratings a good stock to buy now?
    • What is the P/E ratio of CARE Ratings, Edelweiss and LIC?
    • Which of these rating, wealth and insurance franchise stocks has the highest return on equity?
    • What are the risks of investing in rating, wealth and insurance franchise stocks?
    • How did CARE Ratings, Edelweiss and LIC perform in Q1 FY27?
    • Do rating, wealth and insurance franchise stocks pay dividends?
    • How can I invest in rating, wealth and insurance franchise stocks in India?

What Are Rating, Wealth and Insurance Franchise Stocks?

Rating, wealth and insurance franchise stocks are shares of companies that earn fees and premiums from ratings, advice, funds and insurance. Results depend on fee income, premium growth and market activity, so premium growth and fee income separate the stronger names.

Rating, Wealth and Insurance Franchise Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three rating, wealth and insurance franchise stocks as of the 9 Oct 2026 close.

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE
CARE Ratings 1,544.20 4,631 25.70 33.32 18.36%
Edelweiss Financial Services 127.89 12,087 16.98 17.72 13.58%
Life Insurance Corporation of India 394.25 480,067 7.99 10.30 32.53%

Among financial services stocks, all three trade at a discount to their industry P/E multiples.

Why Do Rating, Wealth and Insurance Franchise Stocks Have a Strong Roadmap in India?

Rating, wealth and insurance franchise stocks have a strong roadmap in India because more companies raise debt, and more households save and buy insurance, which lifts ratings, wealth and insurance income. Three drivers stand out.

  • Debt market growth: More bond issuance needs credit ratings.
  • Savings shift: Households move money into long-term products.
  • Distribution reach: Agents and advisers extend reach.

CARE Ratings: Rating Fees Anchor the Roadmap

CARE Ratings’ roadmap rests on a credit rating agency that rates debt instruments and provides analytical services to borrowers and lenders, with rating fees linked to debt raised by companies supporting earnings.

Revenue grew from Rs 274.82 crore in FY22 to Rs 527.89 crore in FY26, a 92.1% rise, and FY26 revenue was 16.5% higher than FY25. FY26 net profit rose 24.1% to Rs 173.70 crore. Over four years, net profit rose from Rs 76.83 crore in FY22 to Rs 173.70 crore. In Q1 FY27, revenue grew 17.5% to Rs 126.48 crore, and net profit rose 24.5% to Rs 32.99 crore. Operating margin was 53.32% in FY26 and 44.26% in Q1 FY27 against 44.12% a year earlier.

Debt to equity is 0.03 and return on equity is 18.36%. FY26 operating cash flow was Rs 147.57 crore against capital expenditure of Rs 8.30 crore. CARE Ratings paid a dividend of Rs 22 per share for FY26, a yield of 1.43%. At a P/E of 25.70 against an industry P/E of 33.32, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 44.26% against 53.32% for FY26, so margin stability is the figure to follow as volumes grow.

Edelweiss Financial Services: Asset Management and Wealth Drive the Pipeline

Edelweiss’ roadmap rests on alternative asset management, wealth management, life insurance and credit, with growing client assets supporting fee income.

Revenue grew from Rs 7,212.59 crore in FY22 to Rs 10,865.14 crore in FY26, a 50.6% rise, and FY26 revenue was 14.1% higher than FY25. FY26 net profit rose 27.0% to Rs 680.46 crore. Over four years, net profit rose from Rs 212.07 crore in FY22 to Rs 680.46 crore. In Q1 FY27, revenue grew 6.0% to Rs 2,418.81 crore, and net profit rose 30.9% to Rs 134.37 crore.

Debt to equity is 4.02 and return on equity is 13.58%. Edelweiss paid a dividend of Rs 1.5 per share for FY26, a yield of 1.17%. At a P/E of 16.98 against an industry P/E of 17.72, the stock trades below its industry multiple.

What to watch: The P/E of 16.98 against an industry P/E of 17.72 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.

Life Insurance Corporation of India: A Vast Policyholder Base Anchors the Roadmap

LIC’s roadmap rests on life insurance and annuity products sold through the largest agent network in India, with a vast policyholder base supporting premium income.

Revenue grew from Rs 728,945.50 crore in FY22 to Rs 990,211.25 crore in FY26, a 35.8% rise, and FY26 revenue was 10.2% higher than FY25. FY26 net profit rose 18.9% to Rs 57,453.15 crore. In Q1 FY27, revenue grew 7.0% to Rs 241,166.45 crore, and net profit rose 24.0% to Rs 13,584.25 crore.

Return on equity is 32.53%. LIC paid a dividend of Rs 10 per share for FY26, a yield of 1.32%. At a P/E of 7.99 against an industry P/E of 10.30, the stock trades below its industry multiple.

What to watch: The P/E of 7.99 against an industry P/E of 10.30 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.

Best Rating, Wealth and Insurance Franchise Stocks in India: CARE Ratings vs Edelweiss vs LIC on Key Financials

Among the best rating, wealth and insurance franchise stocks in India, CARE Ratings leads on FY26 revenue growth and Q1 FY27 revenue growth; Edelweiss leads on Q1 FY27 net profit growth and FY26 net profit growth; LIC leads on return on equity and the lowest P/E. The table puts the numbers side by side.

Metric CARE Ratings Edelweiss LIC
FY26 revenue (Rs Cr) 527.89 10,865.14 990,211.25
FY26 revenue growth 16.5% 14.1% 10.2%
FY26 net profit (Rs Cr) 173.70 680.46 57,453.15
FY26 net profit growth 24.1% 27.0% 18.9%
Q1 FY27 revenue growth (YoY) 17.5% 6.0% 7.0%
Q1 FY27 net profit growth (YoY) 24.5% 30.9% 24.0%
Return on equity 18.36% 13.58% 32.53%
P/E ratio 25.70 16.98 7.99
Dividend yield 1.43% 1.17% 1.32%

Financial earnings follow fee income, premium growth and market activity, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Rating, Wealth and Insurance Franchise Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen rating, wealth and insurance franchise stocks and shortlist rating, wealth and insurance franchise stocks to buy.

  1. Compare each stock’s P/E with its industry P/E, which differs by company here.
  2. Check fee income, premium growth and return on equity together.
  3. Check whether revenue growth is turning into profit growth, not only sales.
  4. Read loan growth against funding costs to see how growth is financed.
  5. Watch capital adequacy and asset quality before sizing a position.
  6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these rating, wealth and insurance franchise stocks

Risks to Consider Before Investing in Rating, Wealth and Insurance Franchise Stocks

  • Market swings: Equity market moves can affect income.
  • Regulation: Rule changes on fees and products can affect margins.
  • Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track CARE Ratings, Edelweiss and LIC live.

Annual reports and quarterly result presentations are the most reliable places to verify the numbers quoted here, because they show segment details, management commentary and the notes behind each figure.

Comparing a quarter with the same quarter of the previous year gives a cleaner reading than comparing it with the preceding quarter, since seasonal patterns affect many businesses in India.

Final Take: Which Stock Has the Strongest Roadmap?

These three financial services stocks cover credit ratings, wealth and asset management and life insurance. CARE Ratings leads on FY26 revenue growth and Q1 FY27 revenue growth; Edelweiss leads on Q1 FY27 net profit growth and FY26 net profit growth; LIC leads on return on equity and the lowest P/E.

Across rating, wealth and insurance franchise stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the rating, wealth and insurance franchise stocks to buy discussed here.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Rating, Wealth and Insurance Franchise Stocks

Which are the best rating, wealth and insurance franchise stocks in India with a strong roadmap?

Ans. CARE Ratings, Edelweiss Financial Services and Life Insurance Corporation of India stand out for their roadmaps in credit ratings, wealth and asset management and life insurance. FY26 revenue growth was 16.5% at CARE Ratings, 14.1% at Edelweiss and 10.2% at LIC, and return on equity ranges from 13.58% to 32.53%.

Is CARE Ratings a good stock to buy now?

Ans. CARE Ratings has a debt to equity ratio of 0.03, a return on equity of 18.36% and a P/E of 25.70 against an industry P/E of 33.32. Valuation, market activity and regulation move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of CARE Ratings, Edelweiss and LIC?

Ans. The P/E ratio is 25.70 for CARE Ratings (industry 33.32), 16.98 for Edelweiss (industry 17.72) and 7.99 for LIC (industry 10.30). All of them trade below the industry multiple.

Which of these rating, wealth and insurance franchise stocks has the highest return on equity?

Ans. Life Insurance Corporation of India has the highest return on equity at 32.53%, followed by CARE Ratings at 18.36% and Edelweiss Financial Services at 13.58%.

What are the risks of investing in rating, wealth and insurance franchise stocks?

Ans. The main risks are market swings, regulation and quarterly trends. Equity market moves can affect income.

How did CARE Ratings, Edelweiss and LIC perform in Q1 FY27?

Ans. CARE Ratings reported revenue of Rs 126.48 crore, up 17.5% year on year, and net profit rose 24.5% to Rs 32.99 crore. Edelweiss Financial Services reported revenue of Rs 2,418.81 crore, up 6.0% year on year, and net profit rose 30.9% to Rs 134.37 crore. Life Insurance Corporation of India reported revenue of Rs 241,166.45 crore, up 7.0% year on year, and net profit rose 24.0% to Rs 13,584.25 crore.

Do rating, wealth and insurance franchise stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 1.43% for CARE Ratings, 1.17% for Edelweiss and 1.32% for LIC, based on dividends declared for FY26.

How can I invest in rating, wealth and insurance franchise stocks in India?

Ans. You can buy rating, wealth and insurance franchise stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.



CARE Ratings Edelweiss Financial Services Life Insurance Corporation of India rating wealth and insurance franchise stocks wealth and insurance franchise stocks to buy
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply